Arcus Biosciences, Inc.
RCUSNYSEHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.88B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $15.38$31.74
- Volume (live)
- -
- Avg. volume (3M)
- 1.58M
Arcus Biosciences (RCUS) Stock Price & Financial Analysis
Arcus Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $21.60 - $22.96 |
|---|---|
| 52-Week High | $31.74 |
| 52-Week Low | $15.38 |
| Open | $22.79 |
| Volume (last close) | 1.43M |
| Average Volume (3M) | 1.58M |
| Revenue (TTM) | 117.00M |
|---|---|
| Net Income (TTM) | -452.00M |
| Free Cash Flow (TTM) | -475.00M |
| EPS (TTM) | −$3.88 |
| Profit Margin | -386.32% |
| Operating Margin | -415.38% |
| Return on Equity (ROE) | -97.41% |
| Debt to Equity | 0.25 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.88B |
|---|---|
| Shares Outstanding | 126.10M |
| Price to Sales (P/S) | 24.59 |
| Price to Book (P/B) | 6.20 |
| EV/EBITDA | -6.78 |
| 50-Day MA | $27.16 |
|---|---|
| 200-Day MA | $24.83 |
| 1-Year Change | +38.55% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Arcus Biosciences at a Glance
As of the Oct 16, 2026 close, Arcus Biosciences (RCUS) has a market capitalization of $2.88B. The stock trades at 24.6× sales. Over the trailing twelve months it lost $452.00M on revenue of $117.00M and burned $475.00M of free cash flow. Revenue fell 55.3% year over year.
As of its latest reported balance sheet, it holds $150.00M in cash and securities against $114.00M of debt, a net cash position of $36.00M.
Arcus Biosciences does not currently pay a dividend.
The share price is up 38.6% over the past year. At $22.12 (the Oct 16, 2026 close) it sits within its 52-week range of $15.38 to $31.73, below its 200-day moving average of $24.83.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $38.82, 75.5% above the Oct 16, 2026 close.
Frequently Asked Questions About Arcus Biosciences
What is the current stock price for RCUS?
As of the Oct 16, 2026 close, RCUS stock trades at $22.12. The 52-week range is $15.38–$31.74, with a day range of $21.60–$22.96.
What is the P/E ratio for RCUS?
The P/E ratio (Price-to-Earnings) for RCUS is shown in the Key Statistics section. This valuation metric helps compare Arcus Biosciences, Inc. to industry peers.
Does RCUS pay dividends?
Arcus Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RCUS?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for RCUS is Buy. The average 12-month price target is $38.82, a 75.5% upside from the Oct 16, 2026 close of $22.12.
What is the market cap of RCUS?
As of the Oct 16, 2026 close, Arcus Biosciences's market capitalization is $2.79B, classifying it as a mid-cap company. Arcus Biosciences operates in the Healthcare sector within the Biotechnology industry.